OpenEvidence reportedly raises $250 million at a $15 billion valuation

OpenEvidence, an AI medical-information platform for clinicians, reportedly raised $250 million from hospital systems and Andreessen Horowitz at a $15 billion valuation. Business Insider says the financing lifts the startup above the $12 billion valuation it reached in January and brings its fundraising over the past year to more than $1 billion. The outlet also reports that OpenEvidence could consider a sale partly to secure computing capacity, but says it could not verify any buyer interest and that the company may remain independent.